Page last updated: 2024-08-21

cyclopentane and belinostat

cyclopentane has been researched along with belinostat in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berger, AJ; Chalasani, S; Chen, S; Dai, Y; Dumur, CI; Ferreira-Gonzalez, A; Grant, S; Kmieciak, M; Leng, Y; Li, L; Lin, H; Povirk, L; Rahmani, M; Rizzo, KA; Zhang, Y; Zhou, L1

Other Studies

1 other study(ies) available for cyclopentane and belinostat

ArticleYear
The NAE inhibitor pevonedistat interacts with the HDAC inhibitor belinostat to target AML cells by disrupting the DDR.
    Blood, 2016, 05-05, Volume: 127, Issue:18

    Topics: Animals; Apoptosis; Bcl-2-Like Protein 11; Cell Cycle Proteins; Cells, Cultured; Checkpoint Kinase 1; Cyclopentanes; DNA Damage; DNA Repair; Drug Synergism; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Mice; Molecular Targeted Therapy; Myelodysplastic Syndromes; Neoplasm Proteins; NF-kappa B; Nuclear Proteins; Protein Processing, Post-Translational; Protein-Tyrosine Kinases; Pyrimidines; RNA Interference; RNA, Small Interfering; S Phase Cell Cycle Checkpoints; Sulfonamides; U937 Cells; Ubiquitin-Activating Enzymes; Xenograft Model Antitumor Assays

2016